Cell Therapy
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
84
NCT06045910
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
Phase: Phase 1/2
Role: Collaborator
Start: Feb 7, 2024
Completion: Dec 21, 2029
Loading map...